News for 'Drug Administration'

Indian drug makers face heat of US regulator's crackdown

Indian drug makers face heat of US regulator's crackdown

Rediff.com23 Jun 2013

Data also show that several other leading domestic pharma companies have recalled their products from the US

Bihar cops obtain reference NEET papers, ED likely to join probe

Bihar cops obtain reference NEET papers, ED likely to join probe

Rediff.com22 Jun 2024

The Bihar Police's Economic Offences Unit, which is probing the alleged National Eligibility-cum-Entrance Test (Undergraduate) (NEET-UG) paper leak case, on Saturday claimed to have obtained reference question papers of the test conducted by National Testing Agency (NTA) and planned to compare these with documents recovered from a flat in Patna during a search operation last month.

Wait for Indian generic launches gets longer

Wait for Indian generic launches gets longer

Rediff.com29 Oct 2012

USFDA has extended the timeline for granting tentative approval to generic drug applications filed under Para IV of its rules by 10 months.

Sun Pharma ends patent dispute with Actavis

Sun Pharma ends patent dispute with Actavis

Rediff.com6 Oct 2015

Ranbaxy, its partners and Actavis have signed a non-exclusive agreement.

Ranbaxy gets US nod to sell Alzheimer's generic

Ranbaxy gets US nod to sell Alzheimer's generic

Rediff.com22 Sep 2010

India's largest drugmaker, Ranbaxy, will have an exclusive six-month marketing opportunity to sell a generic version of Japanese drugmaker Eisai's drug for Alzheimer's in the US.

Mexican drug lord 'El Chapo' found guilty; faces life in prison

Mexican drug lord 'El Chapo' found guilty; faces life in prison

Rediff.com13 Feb 2019

Joaquin "El Chapo" Guzman Loera was convicted on numerous counts including money laundering, engaging in a continuing criminal enterprise, distribution of heroin and cocaine and other drugs, and illegal arms possession.

J&J seeks permission for trial of 1-shot Covid vaccine in India

J&J seeks permission for trial of 1-shot Covid vaccine in India

Rediff.com20 Apr 2021

The US Food and Drug Administration had in February approved Johnson & Johnson's COVID-19 vaccine that works with just one dose for emergency use.

RAW official behind Pannun murder plot? Here is what media report says

RAW official behind Pannun murder plot? Here is what media report says

Rediff.com29 Apr 2024

Quoting officials, The Washington Post said, the foiled assassination was part of an escalating campaign of aggression by RAW against the Indian diaspora in Asia, Europe and North America.

Health Canada raps Ranbaxy

Health Canada raps Ranbaxy

Rediff.com28 Feb 2009

Ranbaxy has acceded to the request of Health Canada to quarantine drugs produced from its Paonta Sahib facility at Himachal Pradesh, North American country's newspapers reported, highlighting the trouble in store for the Japanese-controlled drug maker. Health Canada is a department of the government of Canada with responsibility for national public health.

Ranbaxy Lab dips nearly 7% on bourses

Ranbaxy Lab dips nearly 7% on bourses

Rediff.com24 Jun 2013

As per the media report, the US Food and Drug Administration is learnt to have issued a Form 483 to the company's manufacturing facility at Mohali a few months ago after finding deviations from norms during an inspection of the plant.

Indian-origin student found dead in US, shot self in head

Indian-origin student found dead in US, shot self in head

Rediff.com8 Feb 2024

Sameer Kamath, a US citizen, was found dead in the woods on February 5 at approximately 5pm in NICHES Land Trust - Crow's Grove in Williamsport, Indiana.

Ranbaxy introduces whistle-blower policy

Ranbaxy introduces whistle-blower policy

Rediff.com27 May 2013

Patient safety and quality our guidance now, says CEO and MD Arun Sawhney.

US firm drags Lupin to court

US firm drags Lupin to court

Rediff.com19 Mar 2010

Cephalon, a US-based drug maker, has filed a lawsuit against Lupin Ltd and its US subsidiary Lupin Pharmaceuticals for challenging the patents on its sleep disorder drug Nuvigil.

Can Ranbaxy recover from its US debacle?

Can Ranbaxy recover from its US debacle?

Rediff.com2 Feb 2012

USFDA consent decree reveals that firm will have to forego huge short-term opportunities for its generics.

Parliament breach: Five accused taken to Gujarat for polygraph, narco tests

Parliament breach: Five accused taken to Gujarat for polygraph, narco tests

Rediff.com9 Jan 2024

The police officials said all the five accused will have to undergo the polygraph test, while Sagar and Manoranjan will have to undergo additional naro-analysis and brain mapping tests.

Ranbaxy settles case with USFDA, to pay $500 mn

Ranbaxy settles case with USFDA, to pay $500 mn

Rediff.com21 Dec 2011

Drug-maker Ranbaxy Laboratories on Wednesday said it has signed an agreement with the US health regulator to lift a ban on the import of drugs from certain manufacturing plants in India and will pay up to $500 million to settle a case lodged by the Department of Justice.

Daiichi, Ranbaxy team to counter FDA charges

Daiichi, Ranbaxy team to counter FDA charges

Rediff.com27 Feb 2009

The USFDA has accused Ranbaxy of falsifying data and test results of medicines. A Daiichi Sankyo statement said it takes the issue very seriously. 'Both Daiichi and Ranbaxy have formed a team to solve the issue. Ranbaxy will be responding to the FDA and will continue to cooperate with the agency.' Ranbaxy shares fell more than 18 per cent to Rs 169.85 today on the Bombay Stock Exchange, while Daiichi stock dropped about 10 per cent to yen 1,680 on the Tokyo Stock Exchange.

Biden, Trump sweep Super Tuesday primaries, rematch is on

Biden, Trump sweep Super Tuesday primaries, rematch is on

Rediff.com6 Mar 2024

Super Tuesday is an important phase of presidential primaries when the early contests are over, and voters from multiple states cast ballots in primaries timed to occur on the same date. Almost all the results were one-sided in favour of Trump except for Vermont, where the winning difference was about one per cent.

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

Over 1 million new COVID-19 cases reported in US

Over 1 million new COVID-19 cases reported in US

Rediff.com4 Jan 2022

The US health authorities registered more than three times as many new cases as in any previous wave of the coronavirus.

I can stand behind every pill: Ranbaxy CEO

I can stand behind every pill: Ranbaxy CEO

Rediff.com27 May 2013

The US FDA, during its inspection of Ranbaxy's manufacturing facilities in India, between 2006 and 2008, had found violations, incomplete testing records and an inadequate stability programme, besides manufacturing practices that did not follow regulations.

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

Sun eyes US skincare market

Sun eyes US skincare market

Rediff.com18 Apr 2013

Last week, Sun's Israeli subsidiary, Taro Pharma, received the US Food and Drug Administration's approval for its New Drug Application to launch Topicort Topical Spray for the treatment of psoriasis.

Indian generics profit from Glaxo patent expiry

Indian generics profit from Glaxo patent expiry

Rediff.com18 Aug 2009

GlaxoSmithKline Plc's anti-migraine drug brand, Imitrex, is turning out to be a good revenue earner for Indian generic companies.

After a year, Aurobindo Pharma starts getting USFDA nod

After a year, Aurobindo Pharma starts getting USFDA nod

Rediff.com4 Jun 2012

Both the units were under the scanner of FDA since 2011.

Wockhardt gets USFDA nod for anti-depressant tablets

Wockhardt gets USFDA nod for anti-depressant tablets

Rediff.com3 Sep 2012

The company said it is launching the product immediately

Firms go beyond patent cliff for growth

Firms go beyond patent cliff for growth

Rediff.com29 Jan 2013

In the last one month, Indian pharmaceutical company Lupin has won US Food and Drug Administration nod for three of its contraceptive pills, and has at least nine approvals pending with the regulator.

Orion files suit against Wockhardt

Orion files suit against Wockhardt

Rediff.com12 Dec 2008

The Finland-based drug major Orion Corporation has filed a lawsuit in the United States against domestic drug major Wockhardt for challenging the patents on its brand Stalevo, used for the treatment of Parkinson's disease.

'Made in India' dominates US AIDS scheme

'Made in India' dominates US AIDS scheme

Rediff.com16 Oct 2009

Indian drug companies have cornered an overwhelming majority of drug approvals under the US President's Emergency Plan for AIDS Relief.

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Rediff.com24 Jun 2020

The company is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra, Hetero Healthcare said in a statement.

Ranbaxy expects guidance on Dewas unit by December

Ranbaxy expects guidance on Dewas unit by December

Rediff.com12 Nov 2012

Work to begin after that on corrective measures to meet US regulator's requirements.

Ranbaxy, JP Associates to exit Nifty from Mar 28

Ranbaxy, JP Associates to exit Nifty from Mar 28

Rediff.com27 Feb 2014

Tech Mahindra and United Spirits will replace them in the 50-share index of the National Stock Exchange with effect from March 28.

New test can predict your level of immunity against COVID-19

New test can predict your level of immunity against COVID-19

Rediff.com10 Aug 2022

Easy access to this kind of test could help people determine what kind of precautions they should take against COVID-19 infection, such as getting an additional booster shot, the researchers said.

Parkinson's medicine in patent tangle

Parkinson's medicine in patent tangle

Rediff.com4 Nov 2008

Drug major Wockhardt has challenged the US patent of Stalevo, a new generation combination drug for the treatment of Parkinson's disease, originated by Finland-based Orion Corporation and marketed by Novartis.

What you MUST know about cancer

What you MUST know about cancer

Rediff.com4 Oct 2012

Chairman of the Department of Surgical Oncology at Lilavati Hospital in Mumbai, Dr P Jagannath shares interesting insights on how detecting cancer early on has helped many survive the disease.

Ranbaxy faces more trouble in US

Ranbaxy faces more trouble in US

Rediff.com4 Mar 2010

In addition to the US drug regulator, Food and Drug Administration, and rival pharma majors that appear keen to launch litigation against Indian company Ranbaxy, a US citizen has joined the bandwagon by filing a case in the world's biggest drug market.

Cadila gets USFDA nod for new diabetes molecule

Cadila gets USFDA nod for new diabetes molecule

Rediff.com7 Apr 2011

Approval was given by the United States Food and Drug Administration for an investigational new drug application for ZYGK1, Cadila Healthcare said in a filing to the Bombay Stock Exchange.

US gives full approval to Pfizer Covid vaccine

US gives full approval to Pfizer Covid vaccine

Rediff.com23 Aug 2021

More than 200 million Pfizer doses have been administered in the US, and hundreds of millions more worldwide, since December.

Indian pharma companies bullish in the US

Indian pharma companies bullish in the US

Rediff.com6 Mar 2009

Despite the ongoing trouble India's largest drug maker, Ranbaxy, is facing in the United States, domestic pharmaceutical companies are betting high on the world's largest drug market with added vigour.

Sun, Ranbaxy hit by US patent counter-suits

Sun, Ranbaxy hit by US patent counter-suits

Rediff.com15 Jun 2010

US-based Abbott Laboratories has sued Sun Pharmaceutical Industries and Ranbaxy Laboratories in courts there for challenging the patents of its cholesterol-lowering drugs, Niaspan and TriCor, respectively, in separate infringement suits.